Top
Infections following CAR-T therapy. A retrospective collaborative study between the Infectious Diseases Working Party (IDWP), the Cellular Therapy and Immunobiology Working Party (CTIWP), the Transplant Complications Working Party (TCWP) of the EBMT, the European Hematology Association (EHA), and the Medical College of Wisconsin.
Study type
Closed Survey/Study
Diseases
Non-Hodgkin’s Lymphoma (NHL)
Acute Lymphatic Leukaemia (ALL)
Group
GoCART Coalition
Infectious Diseases Working Party (IDWP)
Cellular Therapy & Immunobiology Working Party (CTIWP)
Complications Working Party (CWP)
Type of treatment
CAR T
Principal investigator
Dina Averbuch
Autoimmune and autoinflammatory complications after CAR-T cell therapy - a joint study on behalf of the EBMT - ADWP, CTIWP and TCWP
Study type
Retrospective Studies
Diseases
Acute Lymphatic Leukaemia (ALL)
Multiple Myeloma (MM) or other Plasma Cell Disorder (PCD)
Non-Hodgkin’s Lymphoma (NHL)
Group
GoCART Coalition
Autoimmune Diseases Working Party (ADWP)
Cellular Therapy & Immunobiology Working Party (CTIWP)
Complications Working Party (CWP)
Type of treatment
CAR T
Principal investigator
Matteo Doglio